Colgate-Palmolive Company $CL Position Raised by Flputnam Investment Management Co.

Flputnam Investment Management Co. increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 7.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 200,972 shares of the company’s stock after purchasing an additional 13,804 shares during the period. Flputnam Investment Management Co.’s holdings in Colgate-Palmolive were worth $15,881,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. CBIZ Investment Advisory Services LLC increased its holdings in shares of Colgate-Palmolive by 86.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after buying an additional 150 shares in the last quarter. Maseco LLP bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $27,000. Copia Wealth Management bought a new position in shares of Colgate-Palmolive in the third quarter valued at $29,000. Cloud Capital Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at $30,000. Finally, Global Wealth Strategies & Associates increased its holdings in shares of Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after buying an additional 300 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.5%

Colgate-Palmolive stock opened at $90.16 on Wednesday. The company’s fifty day simple moving average is $86.19 and its 200-day simple moving average is $85.41. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a market cap of $72.34 billion, a P/E ratio of 35.08, a P/E/G ratio of 4.71 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. During the same period in the previous year, the company posted $0.91 EPS. Colgate-Palmolive’s revenue was up 8.4% on a year-over-year basis. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.82 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were issued a dividend of $0.53 per share. The ex-dividend date was Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is presently 82.49%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CL. TD Cowen reaffirmed a “hold” rating and issued a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. UBS Group upped their price target on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a report on Monday, May 4th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Piper Sandler dropped their price target on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Finally, Bank of America dropped their price target on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a report on Friday, April 10th. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.